ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4974
0.18%
Brent Oil
81.985
-0.17%
Bitcoin
66,434.44
-0.31%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Morphic Holding Inc (MORF)

  7. Morphic Holding Inc (MORF) Noticias

MORF

Morphic (MORF)

Morphic Holding Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MORF
FechaHoraFuenteTítuloSímboloCompañía
05/06/202418:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MORFMorphic Holding Inc
05/06/202415:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MORFMorphic Holding Inc
31/05/202407:00GlobeNewswire Inc.Morphic to Participate in Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
21/05/202407:00GlobeNewswire Inc.Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking CellsNASDAQ:MORFMorphic Holding Inc
09/05/202415:05GlobeNewswire Inc.Morphic to Participate in RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
25/04/202406:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024NASDAQ:MORFMorphic Holding Inc
19/03/202407:00GlobeNewswire Inc.Morphic Appoints Dr. Simon Cooper as Chief Medical OfficerNASDAQ:MORFMorphic Holding Inc
05/03/202415:05GlobeNewswire Inc.Morphic to Participate in March Investor ConferencesNASDAQ:MORFMorphic Holding Inc
22/02/202406:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MORFMorphic Holding Inc
22/02/202406:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MORFMorphic Holding Inc
22/02/202406:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023NASDAQ:MORFMorphic Holding Inc
03/01/202415:05GlobeNewswire Inc.Morphic to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
10/11/202307:00GlobeNewswire Inc.Morphic to Present at November Investor ConferencesNASDAQ:MORFMorphic Holding Inc
03/11/202306:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MORFMorphic Holding Inc
03/11/202306:00GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023NASDAQ:MORFMorphic Holding Inc
09/10/202307:00GlobeNewswire Inc.Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data SetNASDAQ:MORFMorphic Holding Inc
26/09/202315:10GlobeNewswire Inc.Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of AbsenceNASDAQ:MORFMorphic Holding Inc
22/09/202316:30GlobeNewswire Inc.Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023NASDAQ:MORFMorphic Holding Inc
07/09/202315:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MORFMorphic Holding Inc
29/08/202307:00GlobeNewswire Inc.Morphic Announces Participation in 2023 Wells Fargo Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
09/08/202315:05GlobeNewswire Inc.Morphic to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:MORFMorphic Holding Inc
03/08/202306:05GlobeNewswire Inc.Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023NASDAQ:MORFMorphic Holding Inc
23/06/202318:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MORFMorphic Holding Inc
06/06/202315:05GlobeNewswire Inc.Morphic to Present at the Jefferies Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
02/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MORFMorphic Holding Inc
12/05/202307:30GlobeNewswire Inc.Morphic to Present at 2023 RBC Capital Markets Global Healthcare ConferenceNASDAQ:MORFMorphic Holding Inc
11/05/202307:00GlobeNewswire Inc.Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative ColitisNASDAQ:MORFMorphic Holding Inc
05/05/202309:30GlobeNewswire Inc.Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:MORFMorphic Holding Inc
04/05/202305:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MORFMorphic Holding Inc
02/05/202323:13GlobeNewswire Inc.Morphic Therapeutic Announces Pricing of $240.0 Million Public OfferingNASDAQ:MORFMorphic Holding Inc
 Showing the most relevant articles for your search:NASDAQ:MORF

Su Consulta Reciente

USOTC
ADDYY
Adidas (QX)
NYSE
MCD
McDonalds
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
FX
EURUSD
Euro vs US Dollar
COIN
SOLUSD
Solana
NASDAQ
AMZN
Amazon.com
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
FX
USDMXN
US Dollar vs MXN
NASDAQ
MSFT
Microsoft
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados